Ambispective Registry of Patients Affected by Lung Cancer
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,500
- 试验地点
- 1
- 主要终点
- 10 years overall survival
研究概览
简要总结
Lung cancer is one of the most common cancers and the leading cause of cancer-related death. It is often diagnosed late, and there are different types of lung cancer. Today, many patients benefit from targeted therapies and immunotherapy, which have improved survival.
This study will create an ambispective clinical registry of all lung cancer patients treated at Policlinico San Matteo.
The registry will collect data from 2019 to 2035 to better understand: 10-year overall survival, how the disease progresses over time, how patients respond to treatments and possible side effects, how patient and tumor characteristics influence treatment choices, how different therapies work in real-world practice.
All data will be securely collected whithin REDCap platform and used to improve future care and research.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients ≥ 18 years diagnosed with and/or treated for lung cancer at the department of SC Oncologia 1 Unit of the Fondazione IRCCS Policlinico San Matteo;
- •Prospective patients (or their or legal guardians) who have the ability to understand and be willing to sign a written informed consent document;
- •Retrospective patients who have signed the institutional document allowing the use of their data for research on their disease.
排除标准
- •Patients who are unable to understand informed consent document.
结局指标
主要结局
10 years overall survival
时间窗: 10 years
次要结局
未报告次要终点
研究者
Francesco Agustoni
Principal Investigator
Fondazione IRCCS Policlinico San Matteo di Pavia